Indexing
All Issues
Submission
Author Guidelines
Reviewers
Editorial Members
Publication Fee
Vol.5 , No. 1, Publication Date: Jan. 20, 2018, Page: 14-28
| [1] | Janis Dundurs, Department of Occupational and Environmental Health, Riga Stradins University, Riga, Latvia. |
| [2] | Johannes Gutknecht, Faculty of Medicine, Riga Stradins University, Riga, Latvia. |
Cannabis is the number one consumed illicit drug globally. The aim of the study was to analyze the socio-demographic data of the cannabis users in Latvia and in Germany, their professional status and to evaluate the proportion of people whose cannabis consumption could be classified as hazardous or problematic. A 38 item questionnaire was designed to categorize cannabis users into the categories ordinary, hazardous, and problematic use. Early “first- in- lifetime- use” could be associated with hazardous or problematic use in both countries. Both hazardous and problematic use is associated with negative impact on occupation. Tools have to be readily available to assess the use by the consumer, and specific programs for treatment of use disorders should be accessible.
Keywords
Cannabis, Illicit Drug, Impact on Physical, Mental, Social Health, Ordinary, Hazardous, Problematic Use
Reference
| [01] | United Nations Office On Drugs And Crime, United Nations World Drug Report 2015; 1. Available at https://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf |
| [02] | World Health Organization. The health and social effects of nonmedical cannabis use. 2016; 10. Available at http://www.who.int/substance_abuse/publications/msbcannabis.pdf |
| [03] | Wikipedia entry “Legality of cannabis by country” on 15.10.2016 https://en.wikipedia.org/wiki/Legality_of_cannabis_by_country |
| [04] | World Health Organization. The health and social effects of nonmedical cannabis use. 2016; 10. Available at http://www.who.int/substance_abuse/publications/msbcannabis.pdf |
| [05] | World Health Organization. The health and social effects of nonmedical cannabis use. 2016; 12. Available at http://www.who.int/substance_abuse/publications/msbcannabis.pdf12 |
| [06] | De Las Cuevas C, Sanz EJ et al. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction Volume 95, Issue 2 February 2000; 245–250 Available at http://onlinelibrary.wiley. com/doi/10.1046/j.1360-0443.2000.95224511.x/abstract;jsessionid=C1A5412428 DA9B48657918D0594C56C0.f04t04 |
| [07] | Piontek D, Kraus L, Klempova D. Short scales to assess cannabis-related problems: a review of psychometric properties. Substance Abuse Treatment, Prevention, and Policy, 2008, Volume 3, Number 1; 25. Available on https://substanceabusepolicy.biomedcentral.com/articles/10.1186/1747-597X-3-25 |
| [08] | Up To Date: Treatment of cannabis use disorder. Available at http://www.uptodate.com/contents/treatment-of-cannabis-use-disorder |
| [09] | Adamson SJ, Kay-Lambkin FJ et al. (2010). An Improved Brief Measure of Cannabis Misuse: The Cannabis Use Disorders Identification Test – Revised (CUDIT-R). Drug and Alcohol Dependence 110: 137-143. Abstract available at https://www.ncbi.nlm.nih.gov/pubmed/20347232 |
| [10] | World Health Organization. The health and social effects of nonmedical cannabis use. 2016; 6f. Available at http://www.who.int/substance_abuse/publications/msbcannabis.pdf |
| [11] | World Health Organization. The health and social effects of nonmedical cannabis use. 2016; 46. Available at http://www.who.int/substance_abuse/publications/msbcannabis.pdf |
